5 stories mentioning AVLN
Every FINWIRES story that references AVLN, newest first.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Jill Carroll, Director, on May 01, 2026, executed a purchase for 277,778 shares in Avalyn Pharma (AVLN) for $5,000,004. Following the Form 4 filing with the SEC, Carroll has control over a total of 2,186,562 common shares of the company, with 2,186,562 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1540171/000119312526201894/xslF345X05/ownership.xml
Avalyn Pharma (AVLN), a clinical-stage drugmaker, said late Wednesday it has priced its upsized initial public offering of about 16.7 million shares at $18.00 apiece, targeting gross proceeds of about $300 million.Shares soared in their trading debut on Nasdaq, up over 50% at about $27.44 in afternoon trading, with intraday trading volume of over 3.65 million.Everspin Technologies (MRAM) reported Thursday an agreement with a US prime contractor to provide Toggle MRAM process technology and engineering services for United States Defense Industrial Base customers. The agreement is valued at $40.0 million and will run over two-and-a-half years.Shares surged 37% as intraday trading volume soared to over 12.6 million from a daily average of about 533,000.Viavi Solutions (VIAV) jumped 15% after its fiscal Q3 results and fiscal Q4 guidance exceeded market expectations.More than 15.1 million shares traded intraday, compared with a daily average of about 5.87 million.Price: $27.00, Change: $+9.00, Percent Change: +50.00%